key: cord-0863705-x8jpxxwk
authors: Gill, Stephen; Graves, Stephen; Lorimer, Michelle; de Steiger, Richard; Ackerman, Ilana; Ellis, Andrew; Page, Richard
title: COVID‐19 impact on joint replacement surgery in Australia in 2020: a nationwide perspective
date: 2022-02-24
journal: ANZ J Surg
DOI: 10.1111/ans.17343
sha: e403b08bd5df0898c8d441553ec20ad9c92eb23e
doc_id: 863705
cord_uid: x8jpxxwk

nan

Joint replacement (JR) is one of the most common and successful surgical procedures performed in Australia, with over 115 000 primary procedures undertaken in 2019. 1 In 2020, most JR surgery was suspended in late March in response to Federal Government directives to allow only emergency and urgent surgery, which did not include elective JR. 2, 3 This suspension was gradually eased over subsequent months, which varied by jurisdiction.

The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) is uniquely positioned to monitor the impact of COVID-19 related restrictions on JR surgery across the country. AOANJRR data indicates that 5503 fewer primary hip, knee or shoulder replacements for OA (which excludes traumarelated replacements) were conducted nationwide in 2020 compared to 2019. As expected, the largest reduction occurred in April, with a 83.7% reduction in primary JRs due to OA compared to April 2019, equating to 6035 procedures (Fig. 1 ). June and July 2020 saw a rebound in the number of primary JRs for OA, increasing by 13.3% compared to the same period in 2019 (Fig. 1) .

The impact of COVID-19 varied by State or Territory throughout the year (Fig. 2) . In Victoria, a second-wave resurgence of COVID-19 led to elective surgery being temporarily re-suspended in July 2020 with a staggered reintroduction thereafter. Not surprisingly, Victoria experienced the largest reduction in JR; primary JR due to OA was down 4338 procedures (19.3%). In contrast, Tasmania, ACT and Queensland increased primary JR in 2020, principally due to substantial increases in activity in the second half of the year.

In addition to reductions in primary JR, the COVID-19 pandemic was associated with a major decline in revision replacement surgery, which is most commonly required for prosthetic loosening, fracture, instability/dislocation and infection. 1 AOANJRR data demonstrate that 1349 fewer hip, knee or shoulder revision procedures occurred in Australia in 2020, representing a 13.0% decrease from 2019.

Hip replacements for fracture were 101 fewer for 2020, a modest 1.2% reduction. Contrary to other types of JR, shoulder replacements secondary to trauma increased by 8.2% in 2020 (69 procedures). For the 3 months April to June 2020, shoulder replacement due to trauma decreased by 6.6%, but increased by 21.6% between July and September, possibly due to physical deconditioning during lockdown and subsequent increased physical activity and falls as COVID-19 restrictions eased. Public hospitals experienced a greater reduction in JRs than private hospitals in 2020 (Fig. 3) . Private hospitals, where approximately two-thirds of JR are performed nationally, rapidly recommenced JR surgery when restrictions eased. In June and July 2020, primary JR for OA exceeded June 2019 levels by 24.9% and 25.0%, respectively, in private hospitals and remained higher than 2019 levels for the remainder of the year. In contrast, primary JR conducted in public hospitals remained below 2019 levels for the entire period March to December. At year's end, primary JR in public hospitals was down 22.6% (6422 procedures), whereas private hospitals increased throughput by 1.3% nationally (919 procedures).

Postponing elective surgery inevitably increases the backlog of people awaiting JR, compounding the effects of increasing demand for JR. Allowing for average year-on-year increases in demand for JR surgery, 102 566 primary hip, knee or shoulder replacements were expected to be performed for OA in 2020 1 ; actual replacements were 8.5% lower (8706 procedures). This unmet need will need to be absorbed by health services over coming months and potentially years. Based on 2020 data, public health services and Victorian health services will be particularly challenged due to the larger reduction in surgical numbers that occurred in these services. Private health services appear better equipped to rapidly increase JR volume and might be able to assist with managing public patients. Ongoing COVID-related restrictions and surgical delay in 2021 and beyond will extend the impact of the pandemic, which will vary according to the spread of the virus in each State and Territory and each jurisdiction's governmental response.

Delaying elective JR surgery prolongs pain and disability, and challenges the notion of what is considered 'elective' surgery. People awaiting JR typically experience moderate to severe joint pain, moderate to severe problems with common activities such as walking, marked reductions in quality of life and psychological distress. 4, 5 The number of patients waiting JR whose health state equated to 'worse than death' nearly doubled in the UK since the onset of the pandemic, and now represents one-quarter to one-third of patients. 6 Given that JR can dramatically reduce pain and improve function, 4,5,7 delaying surgery inevitably defers substantial gains in quality of life and productivity. 8 Despite its challenges, delayed surgery due to the pandemic represents an opportunity to ensure that appropriate nonsurgical interventions are adequately trialled prior to surgery. Guideline-recommended care includes education, exercise, weight management, walking aids and pain medications. 9 Appropriately delivered non-surgical interventions may delay the need for JR surgery and potentially improve postoperative outcomes. 10 Protecting vulnerable populations from contracting COVID-19 is particularly relevant for people awaiting JR surgery. People undergoing JR may be at higher risk of contracting severe COVID-19 due to their older age, obesity and comorbidities. 1, 11 People with COVID-19 are at higher risk of postoperative complications than people without the disease, particularly in older adults. 12 Delaying surgery for at least 7 weeks following COVID-19 infection has been recommended. 13 Prioritizing preoperative vaccination of patients awaiting elective surgery may prevent COVID-19-related deaths. 14 The COVID-19 pandemic has caused profound changes to healthcare delivery and JR surgery is no exception. Responding to the pandemic's 'knock-on effects' will take similar levels of innovation, team work and coordinated funding as those required in response to the direct effects of the pandemic. Assessing the effects of the pandemic using AOANJRR data will continue to assist health care providers, administrators and governments to design and implement appropriate, prioritized and evidence-based responses.

Data may be provided upon reasonable request to the authors.

Stephen Gill: Conceptualization; project administration; writingoriginal draft; writingreview and editing. Stephen Graves: Conceptualization; writingreview and editing. Michelle Lorimer: Data curation; formal analysis; writingreview and editing. Richard de Steiger: Writingreview and editing. Ilana

Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Hip, Knee & Shoulder Arthroplasty: 2020 Annual Report

AOA and subspecialty COVID-19 position statements and advisory documents pack

Australian Institute of Health and Welfare (AIHW)

Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR)

Patient-reported outcomes after hip and knee arthroplasty: results from a large national registry

Collaboration IM-R. The number of patients "worse than death" while waiting for a hip or knee arthroplasty has nearly doubled during the COVID-19 pandemic

Quality-adjusted life years after hip and knee Arthroplasty: health-related quality of life after 12,782 joint replacements

Cost-effectiveness of total hip and knee replacements for the Australian population with osteoarthritis: discreteevent simulation model

The Royal Australian College of General Practitioners (RACGP)

Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

FAOrthA *Barwon Centre for Orthopaedic Research and Education (B-CORE)

and ¶Department of Musculoskeletal Health and Clinical Epidemiology, School of Public Health and Preventive Medicine

Designing a better incision for proximal tibial osteosarcoma resection and reconstruction: a reminder of the skin's vascular anatomy

Ackerman: Writingreview and editing. Andrew Ellis: Writingreview and editing. Richard Page: Conceptualization; writingreview and editing.

Functional limb reconstruction, rather than amputation, has become the 'gold standard' in bony sarcoma management. 1 This is particularly true in the paediatric setting. The resection and reconstruction of massive sarcoma defects in the proximal tibia and knee are particularly complex. This weight-bearing construct requires a sound osseo-articular column, an intact extensor mechanism and robust